Most previous studies have reported that severity of underlying disease, intensive care unit (ICU) stay at infection onset, infection with extended-spectrum β-lactamase (ESBL)-producing or carbapenem-resistant KP (CRKP), and delayed administrations of appropriate therapy are the common risk factors for mortality in patients with KP BSIs (Viale et al., 2013). This evidence concerns the gene NPPA and infection.